Benzinga's Small Cap Movers for Friday November 30, 2012

Below are highlights from Benzinga's daily coverage of small cap securities making big moves:

Shares of Response Genetics

, the Los Angeles, CA CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer, rose 12% Friday on 5 times average volume. Response Genetics announced Thursday that Thomas A. Bologna, Chairman and CEO, will present at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York at 2:30 PM ET on Tuesday, December 4, 2012. Response Genetics closed at $1.38 on Friday.

Shares of Mitel Networks

, the Ottawa, ON provider of business communications and collaboration software and services, rose 29% Friday on 12 times average volume. Mitel announced Thursday, financial results for the second quarter of fiscal 2013 ended October 31, 2012. Non-GAAP net income from continuing operations for the second quarter of fiscal 2013 was $14.2 million, or $0.25 per share, up from $12.6 million, or $0.23 per share, in the same period last year. Revenue from continuing operations for the second quarter of fiscal 2013 was $145.5 million, compared to $154.6 million for the second quarter of fiscal 2012. Mitel Networks closed at $3.31 on Friday.

Shares of Christopher & Banks

, the Plymouth, MN company specializing in women's apparel, rose 24% Friday on 7 times average volume. Christopher & Banks reported Thursday, results for the quarter ending October 27, 2012. For the third quarter of fiscal 2012, the Company reported net sales of $117.3 million, operating income of $3.6 million and net income of $0.10 per diluted share, the first comparable period quarterly profit in ten quarters. Same store sales increased 13.7% in the third quarter of fiscal 2012, as compared to the comparable period last year Christopher & Banks closed at $4.57 on Friday.